Vyvanse shows up as amphetamine on a drug test. Your body converts Vyvanse (lisdexamfetamine) into dextroamphetamine, which is the same active compound found in Adderall and Dexedrine. Standard workplace and clinical drug screens detect this metabolite and flag it as a positive result in the amphetamines category.
Why Vyvanse Triggers an Amphetamine Result
Vyvanse is a prodrug, meaning it’s inactive when you swallow it. After absorption, red blood cells break it down into two components: the amino acid l-lysine (which your body uses normally) and d-amphetamine, which is the part that treats ADHD. This conversion happens in the blood, not in the liver like most other prodrugs.
Because d-amphetamine is the actual substance circulating in your system, drug tests don’t distinguish between someone taking Vyvanse and someone taking any other prescription amphetamine. The test is detecting the same molecule.
Types of Tests and What They Detect
Most drug screening starts with an immunoassay, a quick initial test that checks urine for broad drug classes. The federal workplace cutoff for amphetamines is 1,000 ng/mL. If your sample exceeds that threshold, it’s flagged as a “presumptive positive” and sent for confirmatory testing.
Confirmatory testing uses more precise technology (gas chromatography-mass spectrometry or similar methods) that can identify the specific amphetamine compounds present. This step confirms whether the initial result was accurate and can distinguish amphetamine from methamphetamine. It can also, when requested, run a chiral analysis to determine whether the amphetamine in your system is the d-enantiomer (the type produced by Vyvanse) or the l-enantiomer (which comes from different sources, like certain nasal decongestants).
One thing worth knowing: immunoassay screens occasionally miss amphetamines entirely because of lower sensitivity for this drug class compared to others. So it’s possible, though uncommon, for a therapeutic dose to fall below the detection cutoff.
How Long Vyvanse Stays Detectable
The detection window depends on the type of test. A 2024 study of healthy volunteers given single therapeutic doses found that amphetamine from lisdexamfetamine remained detectable in urine for a median of about 77 hours, roughly three days. In oral fluid (saliva), the median detection window was about 67 hours. Cleveland Clinic estimates saliva tests detect amphetamines for up to 48 hours in typical screening conditions.
Hair testing has a much longer window. Research on chronic amphetamine users shows positive results for up to about 90 days after the last dose, with detection rates dropping sharply after 120 days. All subjects in one study tested negative by 153 days. Hair tests are less common for routine workplace screening but are used in some legal and forensic settings.
These timelines vary based on your metabolism, hydration, body composition, dose, and how long you’ve been taking the medication. Someone on a daily prescription will accumulate more of the drug than someone who took a single dose.
What Happens When You Have a Prescription
A positive amphetamine result on a workplace drug test doesn’t automatically mean trouble if you have a valid prescription. In federally regulated testing programs, the result goes to a Medical Review Officer (MRO) before your employer sees it. The MRO contacts you and asks whether you have a medical explanation for the result.
To verify your prescription, you’ll need to provide one of the following: a copy of the prescription, the labeled medication container, or a medical record showing valid use during the testing period. The MRO may also contact your prescribing doctor or pharmacist directly to confirm the information.
Once verified, the MRO reports the result to your employer as negative. However, there’s a caveat for certain safety-sensitive jobs. Even with a legitimate prescription, the MRO can notify your employer that you’re taking a medication that could affect your ability to perform safety-critical work. Some occupations, like commercial pilots and certain Department of Transportation roles, have outright restrictions on stimulant medications regardless of prescription status.
Vyvanse vs. Other ADHD Medications on a Test
Vyvanse and Adderall produce overlapping results because both contain d-amphetamine (Adderall also contains l-amphetamine). Standard confirmatory testing cannot tell them apart without additional analysis. If the distinction matters, a lab can run enantiomer-specific testing on request, though this isn’t routine.
Methylphenidate-based medications like Ritalin and Concerta are a different drug class entirely. They do not show up as amphetamines. Standard panels don’t even screen for methylphenidate unless specifically requested.
Non-stimulant ADHD medications like atomoxetine (Strattera) are not expected to trigger amphetamine-positive results. While one case report investigated the possibility, the broader evidence does not support cross-reactivity with standard amphetamine immunoassays.
If You’re Tested Without a Prescription
Without a valid prescription, a confirmed positive for amphetamine is reported as a verified positive. In a workplace setting, this typically triggers consequences outlined in the employer’s drug policy. In legal or probationary testing, it may carry additional penalties.
Because confirmatory testing identifies the specific compounds present, claiming the result came from an over-the-counter cold medication or supplement is unlikely to hold up. While some substances (like certain decongestants) can cause false positives on the initial immunoassay screen, they’re weeded out during the confirmation step. The confirmatory test is highly specific and considered the gold standard in forensic and workplace testing.